Biote financials
$1.24+0.81%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44.2M | $44.9M | $46.4M | $48.0M | $48.9M | $49.0M | $49.8M | $51.4M | $49.2M | $46.8M | $45.7M | $45.6M |
| Gross profit | $28.9M | $31.0M | $31.6M | $34.4M | $35.0M | $36.4M | $35.8M | $36.1M | $33.8M | $33.4M | $31.7M | $31.4M |
| Gross margin | 65.4% | 68.9% | 68.0% | 71.8% | 71.6% | 74.3% | 71.8% | 70.3% | 68.8% | 71.3% | 69.4% | 68.9% |
| Operating income | -$4.2M | $3.2M | $6.8M | $8.3M | $10.8M | $9.7M | $2.8M | $12.2M | $6.2M | $10.4M | $5.5M | $7.6M |
| Net income | -$6.6M | $2.3M | $2.0M | $8.2M | $3.2M | $13.7M | $3.7M | $10.7M | -$7.1M | -$4.2M | $7.7M | $7.5M |
| Net margin | −14.8% | 5.1% | 4.2% | 17.1% | 6.5% | 28.0% | 7.4% | 20.8% | −14.4% | −8.9% | 16.9% | 16.5% |
| Diluted EPS | $-0.23 | $0.06 | $0.05 | $0.22 | $0.10 | $0.37 | $0.10 | $0.33 | $-0.21 | $-0.12 | $0.23 | $0.24 |
| EBITDA | -$2.5M | $4.1M | $7.8M | $9.2M | $11.7M | $10.5M | $3.9M | $13.0M | $7.1M | $11.2M | $7.0M | $8.0M |
| Operating cash flow | -$1.2M | $3.9M | $7.6M | $14.1M | $7.1M | $6.5M | $12.4M | $15.6M | $9.9M | $7.4M | $7.0M | $160.0K |
| Free cash flow | -$3.7M | $3.5M | $5.2M | $13.4M | $5.3M | $4.8M | $11.3M | $13.6M | $7.1M | $6.3M | $6.0M | -$324.0K |
| Diluted shares | 28.6M | 36.0M | 41.3M | 36.7M | 31.7M | 37.0M | 37.1M | 32.3M | 33.1M | 34.6M | 33.5M | 31.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $11.2M | $5.3M | $24.1M | $28.0M | $19.6M | $41.7M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $121.5M | $105.7M | $107.0M | $103.4M | $104.7M | $106.1M |
| Total assets | $101.7M | $89.0M | $107.6M | $111.3M | $104.8M | $123.4M |
| Total liabilities | $159.9M | $137.0M | $158.0M | $176.8M | $183.6M | $208.2M |
| Shareholders' equity | -$58.2M | -$48.0M | -$50.4M | -$65.5M | -$78.8M | -$84.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology